Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines

Frontiers in Genetics

Volumn 4, Issue MAY, 2013, Pages

  Kim, Ji Eun ^a,b   Leung, Euphemia ^a   Baguley, Bruce C ^a   Finlay, Graeme J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Axl; E cadherin; Melanocyte; Melanoma; MITF

Indexed keywords

EID: 84883545884     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00097     Document Type: Article

References (35)

1. Araki, S., Eitel, J. A., Batuello, C. N., Bijangi-Vishehsaraei, K., Xie, X. J., Danielpour, D., et al. (2010). TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. J. Clin. Invest. 120, 290-302. doi: 10.1172/JCI39194
2. Baguley, B. C. (2011). The paradox of cancer cell apoptosis. Front. Biosci. 16, 1759-1767. doi: 10.2741/3819
3. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K. S., et al. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426-3439. doi: 10.1101/gad.406406
4. Charters, G. A., Stones, C. J., Shelling, A. N., Baguley, B. C., and Finlay, G. J. (2011). Centrosomal dysregulation in human metastatic melanoma cell lines. Cancer Genet. 204, 477-485. doi: 10.1016/j.cancergen.2011.07.001
5. Cheli, Y., Giuliano, S., Botton, T., Rocchi, S., Hofman, V., Hofman, P., et al. (2011). Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene 30, 2307-2318. doi: 10.1038/onc.2010.598
6. Cheli, Y., Giuliano, S., Fenouille, N., Allegra, M., Hofman, V., Hofman, P., et al. (2012). Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 31, 2461-2470. doi: 10.1038/onc.2011.425
7. Gadea, G., de Toledo, M., Anguille, C., and Roux, P. (2007). Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J. Cell Biol. 178, 23-30. doi: 10.1083/jcb.200701120
8. Gjerdrum, C., Tiron, C., Hoiby, T., Stefansson, I., Haugen, H., Sandal, T., et al. (2010). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc. Natl. Acad. Sci. U.S.A. 107, 1124-1129. doi: 10.1073/pnas.0909333107
9. Goding, C. R. (2000). Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev. 14, 1712-1728. doi: 10.1101/gad.14.14.1712
10. He, S., Li, C. G., Slobbe, L., Glover, A., Marshall, E., Baguley, B. C., et al. (2011). PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression. Melanoma Res. 21, 24-34. doi: 10.1097/CMR.0b013e328341c7e0
11. Hodgkinson, C. A., Moore, K. J., Nakayama, A., Steingrimsson, E., Copeland, N. G., Jenkins, N. A., et al. (1993). Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74, 395-404. doi: 10.1016/0092-8674(93)90429-T
12. Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Dobbeling, U., Kobert, N., Schaerer, L., et al. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650-656. doi: 10.1158/0008-5472.CAN-07-2491
13. Hoek, K. S., and Goding, C. R. (2010). Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23, 746-759. doi: 10.1111/j.1755-148X.2010.00757.x
14. Ivaska, J. (2011). Vimentin: central hub in EMT induction?. Small GTPases 2, 51-53. doi: 10.4161/sgtp.2.1.15114
15. Jeffs, A. R., Glover, A. C., Slobbe, L. J., Wang, L., He, S., Hazlett, J. A., et al. (2009). A gene expression signature of invasive potential in metastatic melanoma cells. PLoS ONE 4:e8461. doi: 10.1371/journal.pone.0008461
16. Kim, J. E., Shepherd, P. R., and Chaussade, C. (2009). Investigating the role of class-IA PI 3-kinase isoforms in adipocyte differentiation. Biochem. Biophys. Res. Commun. 379, 830-834. doi: 10.1016/j.bbrc.2008.12.089
17. Kim, J. E., Stones, C., Joseph, W. R., Leung, E., Finlay, G. J., Shelling, A. N., et al. (2012). Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines. BMC Cancer 12:141. doi: 10.1186/1471-2407-12-141
18. Kuphal, S., and Bosserhoff, A. K. (2012). E-cadherin cell-cell communication in melanogenesis and during development of malignant melanoma. Arch. Biochem. Biophys. 524, 43-47. doi: 10.1016/j.abb.2011.10.020
19. Li, G., Satyamoorthy, K., Meier, F., Berking, C., Bogenrieder, T., and Herlyn, M. (2003). Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 22, 3162-3171. doi: 10.1038/sj.onc.1206455
20. Lim, J., and Thiery, J. P. (2012). Epithelial-mesenchymal transitions: insights from development. Development 139, 3471-3486. doi: 10.1242/dev.071209
21. Marshall, E. S., Finlay, G. J., Matthews, J. H., Shaw, J. H., Nixon, J., and Baguley, B. C. (1992). Microculture-based chemosensitivity testing: a feasibility study comparing freshly explanted human melanoma cells with human melanoma cell lines. J. Natl. Cancer Inst. 84, 340-345. doi: 10.1093/jnci/84.5.340
22. Marshall, E. S., Matthews, J. H. L., Shaw, J. H. F., Nixon, J., Tumewu, P., Finlay, G. J., et al. (1994). Radiosensitivity of new and established human melanoma cell lines: comparison of 3H-thymidine incorporation and soft agar clonogenic assays. Eur. J. Cancer 30A, 1370-1376. doi: 10.1016/0959-8049(94)90188-0
23. Orgaz, J. L., and Sanz-Moreno, V. (2013). Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell Melanoma Res. 26, 39-57. doi: 10.1111/pcmr.12041
24. Parmar, J., Marshall, E. S., Charters, G. A., Holdaway, K. M., Shelling, A. N., and Baguley, B. C. (2000). Radiation-induced cell cycle delays and p53 status of early passage melanoma cell lines. Oncol. Res. 12, 149-155.
25. Quintana, E., Shackleton, M., Foster, H. R., Fullen, D. R., Sabel, M. S., Johnson, T. M., et al. (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18, 510-523. doi: 10.1016/j.ccr.2010.10.012
26. Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., and Morrison, S. J. A. (2008). Efficient tumour formation by single human melanoma cells. Nature 456, 593-598. doi: 10.1038/nature07567
27. Sanchez-Martin, M., Perez-Losada, J., Rodriguez-Garcia, A., Gonzalez-Sanchez, B., Korf, B. R., Kuster, W., et al. (2003). Deletion of the SLUG (SNAI2) gene results in human piebaldism. Am. J. Med. Genet. 122A, 125-132. doi: 10.1002/ajmg.a.20345
28. Sanchez-Martin, M., Rodriguez-Garcia, A., Perez-Losada, J., Sagrera, A., Read, A. P., and Sanchez-Garcia, I. (2002). SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum. Mol. Genet. 11, 3231-3236. doi: 10.1093/hmg/11.25.3231
29. Selzer, E., Wacheck, V., Lucas, T., Heere-Ress, E., Wu, M., Weilbaecher, K. N., et al. (2002). The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Cancer Res. 62, 2098-2103.
30. Sensi, M., Catani, M., Castellano, G., Nicolini, G., Alciato, F., Tragni, G., et al. (2011). Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase. J. Invest. Dermatol. 131, 2448-2457. doi: 10.1038/jid.2011.218
31. Shirley, S. H., Greene, V. R., Duncan, L. M., Torres Cabala, C. A., Grimm, E. A., and Kusewitt, D. F. (2012). Slug expression during melanoma progression. Am. J. Pathol. 180, 2479-2489. doi: 10.1016/j.ajpath.2012.02.014
32. Steingrimsson, E., Moore, K. J., Lamoreux, M. L., Ferré-D'Amaré, A. R., Burley, S. K., Zimring, D. C., et al. (1994). Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat. Genet. 8, 256-263. doi: 10.1038/ng1194-256
33. Stones, C. S., Kim, J. E., Leung, E., Marshall, E. S., Joseph, W. R., Finlay, G. J., et al. (2013). Comparison of responses of melanoma cell lines to the MEK inhibitor CI-1040 and the BRAF inhibitor vemurafenib. Front. Genet. 4:66. doi: 10.3389/fgene.2013.00066
34. Strub, T., Giuliano, S., Ye, T., Bonet, C., Keime, C., Kobi, D., et al. (2011). Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30, 2319-2332. doi: 10.1038/onc.2010.612
35. Yasumoto, K. I., Amae, S., Udono, T., Fuse, N., Takeda, K., and Shibahara, S. (1998). A big gene linked to small eyes encodes multiple Mitf isoforms: many promoters make light work. Pigment Cell Res. 11, 329-336. doi: 10.1111/j.1600-0749.1998.tb00491.x